These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8017286)

  • 1. Metabolic risk factors for atherosclerosis in heart transplant recipients.
    Kemna MS; Valantine HA; Hunt SA; Schroeder JS; Chen YD; Reaven GM
    Am Heart J; 1994 Jul; 128(1):68-72. PubMed ID: 8017286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormalities following heart transplantation in patients with idiopathic cardiomyopathy.
    Sheu WH; Wei J; Jeng CY; Fuh MM; Chen YD
    Horm Metab Res; 1995 Oct; 27(10):469-72. PubMed ID: 8575727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.
    Becker DM; Chamberlain B; Swank R; Hegewald MG; Girardet R; Baughman KL; Kwiterovich PO; Pearson TA; Ettinger WH; Renlund D
    Am J Med; 1988 Nov; 85(5):632-8. PubMed ID: 3055976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
    Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
    Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
    Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development and progression of dyslipidemia after heart transplantation.
    Akhlaghi F; Jackson CH; Parameshwar J; Sharples LD; Trull AK
    Transplantation; 2002 Apr; 73(8):1258-64. PubMed ID: 11981418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease risk markers in users of low-dose oral contraceptives.
    Godsland IF; Crook D; Wynn V
    J Reprod Med; 1991 Mar; 36(3 Suppl):226-37. PubMed ID: 2046076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics.
    Nielsen NE; Olsson AG; Swahn E
    J Intern Med; 2000 Jan; 247(1):43-52. PubMed ID: 10672130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study.
    Valantine H; Rickenbacker P; Kemna M; Hunt S; Chen YD; Reaven G; Stinson EB
    Circulation; 2001 May; 103(17):2144-52. PubMed ID: 11331254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.
    Jovinge S; Hamsten A; Tornvall P; Proudler A; Båvenholm P; Ericsson CG; Godsland I; de Faire U; Nilsson J
    Metabolism; 1998 Jan; 47(1):113-8. PubMed ID: 9440488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
    Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect?
    Dhawan J; Bray CL; Warburton R; Ghambhir DS; Morris J
    Br Heart J; 1994 Nov; 72(5):413-21. PubMed ID: 7818957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different postprandial lipid metabolism and insulin resistance between non-diabetic patients with and without coronary artery disease.
    Nakamura A; Monma Y; Kajitani S; Kozu K; Ikeda S; Noda K; Nakajima S; Endo H; Takahashi T; Nozaki E
    J Cardiol; 2015 Nov; 66(5):435-44. PubMed ID: 25840497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.